Search results
Guardant Health Stock Jumps. Blood Test for Cancer Moves Toward FDA Approval.
Barrons.com· 9 hours agoShares of Guardant Health were rising sharply after the cancer company said a Food and Drug...
Guardant wins FDA AdCom backing for colon cancer test
Medical Device Network via Yahoo Finance· 14 hours agoThe FDA AdCom voted 7-2 in favour of the Shield test stating that the test’s potential benefits...
FDA panel recommends approval of a blood test for colon cancer
NBC NEWS· 1 day agoAdvisers to the U.S. Food and Drug Administration on Thursday recommended for the approval of...
Cancer Biotech Stocks Are on the Move Ahead of a Big Event. What to Know.
Barrons.com· 10 hours agoThe American Society of Clinical Oncology is set to gather on May 31 in Chicago for its annual...
Docs support drug regulator’s move to withdraw Olaparib for some cancer patients
Investing.com· 2 days agoDrug Controller General of India's (DCGI) mandate to state authorities to withdraw AstraZeneca’s...
HPV vaccine linked to sharp reduction in risk of cancers in men
UPI· 8 hours agoDevelopment and uptake of the human papilloma virus (HPV) vaccine has been crucial in reducing rates...
Michael Strahan's Daughter Reveals Heartbreaking Update in Her Cancer Battle
The Root· 11 hours agoMichael Strahan’s daughter Isabella just shared a heartbreaking update in her battle with brain ...
Zantac didn’t cause 89-year-old woman’s cancer, jury says in first trial over drug
NY Post via Yahoo News· 1 day agoIllinois resident Angela Valadez had alleged that her cancer was a result of taking over-the-counter...
J&J plans for capped, flexible dosing after four patient deaths in early study of actinium prostate ...
Endpoints News· 1 day agoAn experimental prostate cancer drug developed by Johnson & Johnson that uses a rare radioactive particle called actinium-225 led to three patients seeing ...
Novel drug for male contraception shows early signs of efficacy in Promega-sponsored study in mice
FierceBiotech· 13 hours agoSynthetic derivatives of testosterone called dimethandrolone undecanoate (DMAU) and 11b-MNTDC are being tested as reversible male contraceptives in clinical trials but there are concerns about ...